New vaccines, the vaccine wars, schadenfreude, and a feel-good story

Across the world, the pandemic has slowed for the past two weeks. If anyone has an explanation for that, I haven’t found it. It could just be a statistical glitch, but let’s take a deep breath and enjoy the moment.

 

The new vaccines

Two new vaccines have been announced. One, from Johnson & Johnson (and, just to confuse things, Janssen) needs only a single injection. It’s 66% effective against symptomatic disease and 85% effective against the severe forms. And 100% effective against the forms that are so bad that you end up hospitalized or dead.

Only 66%? you ask. That’s pretty damn good by vaccine standards. But the earliest Covid vaccines came back with such high levels of effectiveness that we’ve started to turn up our noses at a measly 66%. Back before the first vaccine trials uncorked their sparking test results, though, 50% was considered good. And 85% and 100% against the severe forms of the disease, when you think about it? Not bad.

The Johnson & Johnson/Janssen vaccine is easy to transport and doesn’t have to be kept at a zillion degrees below freezing, making it a handy addition to the vaccine armory. And it only needs one dose. That’s a major advantage.

Irrelevant photo: The daffodils are just starting to blossom. Really. In January.

A new British vaccine, Novavax, is 89% effective but needs two doses. On the positive side, it can be stored in an ordinary refrigerator and has no objections to being wedged in at the back between the peanut butter and that can of cat food you thought you’d lost.

Both are effective against the South African variant, although the numbers aren’t as high. The new Brazilian variant, I believe, came along too late to be included in any of the trials. That’s the one to keep your eye on right now.

*

A post or three back, I included a news snippet involving Germany, the AstraZeneca vaccine, and the elderly. I now officially wish I’d waited, because we were only halfway through the story. 

In our last episode, some anonymous source in Germany said (publicly, or we wouldn’t know about it) that the AZ vaccine wasn’t effective on the elderly, and some known source said, “Of course it is. You mixed up your numbers,” but refrained from adding, “You idiot.”

And now, in our next episode, a German official body of one sort or another said the vaccine hadn’t been shown to be effective on the elderly, and several other sources jumped into the discussion and I crawled under the bed and sulked for several days. 

Then Emmanuel Macron said something but I hadn’t included him in my post so I didn’t care.

I do take my responsibilities here seriously.

When I emerged, I was covered in dust but felt a little better because the floorboards under my bed were now spotless.

But you wanted to know about the vaccine, didn’t you? 

Is it effective on people over 65? AZ added older people to its vaccine trials later than younger people, so it has less data on them. And it turned out–predictably–that they were more likely to stay away from other people, so both the group that got the vaccine and the group that got the placebo were relatively well protected. That meant fewer deaths (good) and therefore less data (bad).

The trial did include some checks on people’s antibody levels, though, so they have every indication that the vaccine was working.

 

The vaccine wars replace the Brexit wars

Britain and the European Union agree on only one thing lately, and that’s that with a Brexit agreement in place they needed something new to fight about so it was time to toss vaccines into the mix.

AstraZeneca signed a contract to supply the EU with 80 million doses of its vaccine for the first quarter of 2021. Before that, it had signed a different contract to supply Britain with 2 million doses a week. Then it had production problems at its plants in Europe and said it could only supply the EU with 30 million doses. That would be for the first quarter of 2021. 

Pfizer is also producing less of its vaccine than it expected, and in a rare and impressive display of cooperation a second company, Sanofi, whose own vaccine development has been delayed, said it will use its plants to produce Pfizer’s. 

The EU wanted AZ’s plants in Britain to make up the shortfall its plants in Europe were leaving. AZ said that wasn’t not part of the contract. The EU has been slow in starting its vaccination program and is feeling ever so slightly frantic about this.

Britain said it wasn’t interested in getting less than its contracted share of the vaccine, and Boris Johnson tousled his hair and poured a lit match onto oily waters, saying, “I am very pleased at the moment that we have the fastest rollout of vaccines in Europe by some way.”

He refrained from blowing a raspberry until the press conference was over and the doors had closed behind him.

The EU said, fine, it would deal with the shortfall by refusing to allow vaccines to be exported. That would mean no Pfizer vaccine getting into Britain, although there’s a contract there too.

Then the EU said it would use a clause in the Brexit agreement and institute checks at the Irish/Northern Irish border to make double sure to keep vaccines in the EU. Then it said it wouldn’t.

Then everyone involved arched their backs, fluffed their fur, and made the kind of spitting sounds that eight-week-old kittens make when they want to look scary.

Then the EU published the text of its contract with AZ, minus a few clauses that may or may not be relevant.  

Legal experts working their way through the AZ/EU contract say it’s likely to end up either in arbitration or in court. One of them used a (translated) German phrase that means clear as mud, saying it’s clear as noodle soup. 

 

Department of schadenfreude

A multimillionaire couple flew into an isolated, largely indigenous community in the Yukon Territory and claimed to be local motel workers so they could get in on a vaccination program meant primarily for elders and the vulnerable. 

They also didn’t bother observing the fourteen days of quarantine that were required for incomers.

They’ve been fined C$2,300 , but given their economic status that’s not likely to hold their attention, so they also face six months in jail.

The C in C$2,300 stands for Canadian. And schadenfreude stands for a German word meaning enjoying other people’s bad fortune.

Admit it: You’ve done it at least once in your life.

*

Speaking of schadenfreude, Oklahoma spent $2 million buying itself a stockpile of hydroxychloroquine when Donald Trump was touting it as a miracle cure for Covid. Now it’s trying to unload the stuff. Studies show it has no effect on Covid but it could cause heart problems. It’s an accepted treatment for malaria, but you’d be hard put to catch that in Oklahoma. 

The state’s been trying to sell it for months now. If you’re interested, contact the state’s attorney general. You could probably get a bargain.

 

And finally, a feel-good Covid story

A group of health workers in Oregon got stranded on a highway in a snowstorm with six doses of vaccine that would become unusable if they didn’t get into six people’s arms in one hell of a hurry. They’d just finished a clinic and the shots were all committed to specific people, but they weren’t going to reach them in time.

Rather than see them go to waste, they went from up and down the road offering them to people stranded in nearby cars. An ambulance was stuck in the snow with them, so if anyone had a bad reaction, they were covered.

The county health director said it was one of the coolest operations he’d ever been part of.

The pandemic update from Britain, with half-dressed politicians and questionable databases

The European Parliament–unlike the British one–is meeting virtually, and an Irish member, Luke Flanagan (called Ming, after a character out of Flash Gordon) discussed agricultural policy, live and beamed to an unwilling world, while wearing a dark shirt and possibly underwear but nothing more than that. 

We know this because he set his iPad to portrait instead of landscape. And I understand that tastes differ, but I’m reasonably sure this isn’t the portrait you want hanging over your mantle. 

The EU’s translators could be heard fighting not to laugh as they (heroically) went on translating what he said into all the EU’s many languages. 

He now calls himself Ming the Trouserless. 

Irrelevant photo to give you some relief from the pandemic: a field with corn marigolds.

*

Possibly for fear of an online dress-code rebellion, Boris Johnson backed down and will now allow Britain’s members of parliament to vote remotely if they have medical conditions that would make attending in person dangerous or if they have family members who etc. and so on and so on. 

As far as I can tell, that doesn’t include MPs who in spite of the virus have to travel from way to hell and gone to get to Westminster, and it’s anyone guess whether it includes black, Asian, or minority ethnic MPS, who are at higher risk from the virus than whites, for reasons that haven’t been figured out yet. 

*

Since the MPs have come home to roost, chickenlike, in Westminster, the union that represent parliament’s staff is threatening to strike over conditions they consider unsafe. They haven’t been able to keep a safe distance from the MPs, they say. But (they didn’t say) they’re all dressed very nicely–not to mention from top to (and this is very important) bottom.

*

Starting in mid-June, all hospital visitors and outpatients will have to wear masks, and all staff will have to wear surgical masks, the government announced. To which the National Health Service said, “Gee, it would’ve been nice if you’d talked to us about this beforehand, because it’s going to take a little planning.”

“Planning?” the Department of Impulsive Thinking said. “What’s that?”

The government also announced that a limited number of visitors will be allowed into hospitals, and I haven’t a clue if the hospitals were told about that in advance. Possibly, since they haven’t been heard to scream, “You want what?” in public. 

*

A leaked email from the Department of Grinding Slowly has announced that Britain’s world-beating system of testing people for the coronavirus and tracing their contacts won’t be fully operational until September. Or possibly October.

It hasn’t ruled out the possibility of postponing September and October for up to 90 days so that it can make its target. 

But don’t worry, we’ll all be fine. Car showrooms are reopening. In no time at all, we’ll be able to get haircuts. (I’ve cut my partner’s hair twice now and we’re still together. She wanted to cut mine, but after what she did to the dog I thought maybe I’d let it grow.) You can meet people who are over 5’6” on Thursdays as long as you’re out of doors and the wind’s from the west. If they stand on your left. Children with birthmarks have returned to school. Children without birthmarks will have to wait until next month. 

That report is from the Department of You’ll Never Keep Track of It Anyway. 

Those of us who were born with a sunny disposition, along with any number of scientists, are waiting for a second spike in coronavirus cases. In fact, a group of scientists and medics have called for a public inquiry to prepare for it. 

Anyone want to place bets on whether they’ll be listened to?

*

You might want to sit down before you read this next piece. Not because it’s shocking but because it made me dizzy, and I do have a habit of mixing me up with you, so I just assume you’ll have the same problem.

First we (and by we, of course, I mean I) learned from the Guardian that a small US company, Surgisphere, provided the data behind a couple of articles published in reputable medical journals that claimed Covid-19 patients taking hydroxychloroquine (I hate typing that word) were dying at higher rates than people who weren’t taking it. 

That led to tests of the drug ending early. It was too dangerous.  

But Surgisphere’s extensive database, from which the data was drawn, looked–

Is shaky a polite enough word? Questionable. Let’s settle for questionable. And possibly imaginary.

And Surgisphere, which had listed six employees before the story broke, suddenly listed only three. Some of them have no visible medical, scientific, or data background. The science editor seems to be a science fiction writer and fantasy artist. The marketing executive is an adult model and events hostess. 

An adult model? I’m not sure. It probably just means she’s over eighteen, although maybe she makes a living as a role model for adults. Or appears by video link in front of the European Parliament in her not-quite-altogether. 

Next we learned that the respectable medical publications withdrew the articles because the authors were no longer sure of their data. There were plans to resume the canceled trials of that drug whose name I hate to type. 

But wait: Before anyone had time to check my spelling, we learned that a randomized trial reported that the stuff is useless against Covid-19 and we can all forget about it.

May I never have to type its name again.

*

If you’ve gotten this far, you’ve earned the right to whatever good news I can scrape together, and I did find some. Astra-Zeneca is going into high gear producing a vaccine before its effectiveness has been proven. It’s a gamble. If it works, they’ll have 300 million doses ready to go before the end of the year. If it doesn’t, they’ll have set fire to a significant amount of money. 

This involves partnerships with a range of groups that I won’t list, and it also involves a commitment to make 1 billion doses available to low- and middle-income countries.

*

And finally, a Dutch study raises the hope that vitamin K might protect people against the worst forms of Covid-19. So eat your spinach, kids, along with eggs, blue cheese, and hard cheeses. You can put them together into a very nice omelette, and if you’ve been here for a while you know better than to ask me for a recipe.